-Barbara Leiting Researcher Activity Profile

Research Author Detailed Information 

Barbara Leiting Publication Rate By Year

Barbara Leiting has published 7 paper(s) in 2007, 3 paper(s) in 2008, for a total of 10 research publications in total.

Barbara B Leiting Author Information

LAST NAME: leiting

FIRST NAME: barbara

INITIALS: B

AFFILIATION:

Papers

Barbara Leiting's Publication Record

1. Discovery of 3-aminopiperidines as potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitors. Year Published: 2007
Merck Research Laboratories, Department of Medicinal Chemistry, PO Box 2000, Rahway, NJ 07065, USA. jason_cox@merck.com
2. Design, synthesis, and biological evaluation of triazolopiperazine-based beta-amino amides as potent, orally active dipeptidyl peptidase IV (DPP-4) inhibitors. Year Published: 2007
Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA. jennifer_kowalchick@yahoo.com
3. 4-arylcyclohexylalanine analogs as potent, selective, and orally active inhibitors of dipeptidyl peptidase IV. Year Published: 2007
Department of Medicinal Chemistry, Merck Research Laboratories, Rahway, NJ 07065, USA. david_kaelin@merck.com
4. Imidazopiperidine amides as dipeptidyl peptidase IV inhibitors for the treatment of diabetes. Year Published: 2007
Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA. ping_chen@merck.com
5. Design, synthesis, and biological evaluation of triazolopiperazine-based beta-amino amides as potent, orally active dipeptidyl peptidase IV (DPP-4) inhibitors. Year Published: 2007
Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA. jennifer_kowalchick@yahoo.com
6. 4-arylcyclohexylalanine analogs as potent, selective, and orally active inhibitors of dipeptidyl peptidase IV. Year Published: 2007
Department of Medicinal Chemistry, Merck Research Laboratories, Rahway, NJ 07065, USA. david_kaelin@merck.com
7. Imidazopiperidine amides as dipeptidyl peptidase IV inhibitors for the treatment of diabetes. Year Published: 2007
Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA. ping_chen@merck.com
8. Discovery of Potent and Selective Dipeptidyl Peptidase IV Inhibitors Derived from beta-Aminoamides Bearing Subsituted Triazolopiperazines. Year Published: 2008
dooseop_kim@merck.com.
9. Fluoroolefins as amide bond mimics in dipeptidyl peptidase IV inhibitors. Year Published: 2008
Department of Medicinal Chemistry, Merck & Co. Inc., PO Box 2000, Rahway, NJ 07065, USA. scott_edmondson@merck.com
10. Fluoroolefins as amide bond mimics in dipeptidyl peptidase IV inhibitors. Year Published: 2008
Department of Medicinal Chemistry, Merck & Co. Inc., PO Box 2000, Rahway, NJ 07065, USA. scott_edmondson@merck.com